Atezolizumab (MPDL3280A) is a humanized monoclonal IgG1 antibody selectively targeting programmed death ligand 1 (PD-L1). This antibody is utilized extensively in oncological research to investigate the modulation of the immune system's response against cancer cells. Atezolizumab's specificity for PD-L1 aids in the study of immune checkpoint pathways, potentially leading to new therapeutic strategies in cancer treatment.
Atezolizumab (MPDL3280A) is a humanized monoclonal IgG1 antibody selectively targeting programmed death ligand 1 (PD-L1). This antibody is utilized extensively in oncological research to investigate the modulation of the immune system's response against cancer cells. Atezolizumab's specificity for PD-L1 aids in the study of immune checkpoint pathways, potentially leading to new therapeutic strategies in cancer treatment.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: